Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

7.45USD
13 Jul 2018
Change (% chg)

$0.02 (+0.27%)
Prev Close
$7.43
Open
$7.43
Day's High
$7.55
Day's Low
$7.29
Volume
19,133
Avg. Vol
78,215
52-wk High
$23.68
52-wk Low
$5.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.44 December 14 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 1 1
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 1.75 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 7.50 8.10 6.90 --
Quarter Ending Dec-18 2 18.21 28.60 7.82 --
Year Ending Dec-18 3 40.03 54.90 30.00 14.00
Year Ending Dec-19 3 28.10 43.80 12.50 0.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.44 -0.12 -0.60 --
Quarter Ending Dec-18 3 -0.14 0.21 -0.47 --
Year Ending Dec-18 3 -1.28 -0.71 -1.89 -1.67
Year Ending Dec-19 3 -1.66 -0.98 -2.24 -3.95

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 9.90 10.78 0.88 8.90
Quarter Ending Dec-17 8.88 11.28 2.41 27.12
Quarter Ending Sep-17 3.07 8.78 5.71 186.33
Quarter Ending Jun-17 2.00 0.00 2.00 100.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7.50 7.50 7.50 7.77 --
Quarter Ending Dec-18 18.21 18.21 18.21 14.91 --
Year Ending Dec-18 40.03 40.03 40.03 36.35 14.00
Year Ending Dec-19 28.10 28.10 28.10 18.58 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings